337 related articles for article (PubMed ID: 26519556)
1. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():204-12. PubMed ID: 26519556
[TBL] [Abstract][Full Text] [Related]
2. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D
Miyauchi M; Neugebauer NM; Meltzer HY
J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
[TBL] [Abstract][Full Text] [Related]
4. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
[TBL] [Abstract][Full Text] [Related]
5. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
6. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
[TBL] [Abstract][Full Text] [Related]
7. 5-HT
Huang M; Kwon S; Rajagopal L; He W; Meltzer HY
Psychopharmacology (Berl); 2018 Oct; 235(10):2795-2808. PubMed ID: 30066135
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
Miyauchi M; Neugebauer NM; Sato T; Ardehali H; Meltzer HY
J Psychopharmacol; 2017 Dec; 31(12):1588-1604. PubMed ID: 28946779
[TBL] [Abstract][Full Text] [Related]
9. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
[TBL] [Abstract][Full Text] [Related]
10. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
Hajós M; Hurst RS; Hoffmann WE; Krause M; Wall TM; Higdon NR; Groppi VE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1213-22. PubMed ID: 15523001
[TBL] [Abstract][Full Text] [Related]
11. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction.
Rajagopal L; Soni D; Meltzer HY
Behav Brain Res; 2018 Sep; 350():31-43. PubMed ID: 29763637
[TBL] [Abstract][Full Text] [Related]
12. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
14. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.
Iwamoto K; Mata D; Linn DM; Linn CL
Neuroscience; 2013 May; 237():184-98. PubMed ID: 23402849
[TBL] [Abstract][Full Text] [Related]
16. Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat.
Wadenberg MG; Manetti D; Romanelli MN; Arias HR
Behav Brain Res; 2017 Aug; 333():129-134. PubMed ID: 28684359
[TBL] [Abstract][Full Text] [Related]
17. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
[TBL] [Abstract][Full Text] [Related]
18. Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.
Pandya AA; Yakel JL
Neuropharmacology; 2013 Jul; 70():35-42. PubMed ID: 23321689
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement.
Huang M; Kwon S; Oyamada Y; Rajagopal L; Miyauchi M; Meltzer HY
Pharmacol Biochem Behav; 2015 Nov; 138():49-57. PubMed ID: 26383990
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical arguments for the use of dopamine D
Huang M; Kwon S; He W; Meltzer HY
Pharmacol Biochem Behav; 2017 Jun; 157():16-23. PubMed ID: 28455126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
